Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000009

Principal Accounting Officer sold 504 shares at $31.25 ($15,750)

  • Principal Accounting Officer gave up 127 shares (to pay taxes)
  • Principal Accounting Officer acquired 360 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Washburn Theodore James Jr. · Principal Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-14 Exercise or conversion : show line 1 in the form +360 3,413 D
2022-02-14 Shares withheld for taxes : show line 2 in the form −127 $30.50 $3,874 3,286 D
2022-02-14 Sale : show line 3 in the form −504 $31.25 $15,750 2,782 D
Open-market sales · 504 sh · avg $31.25 · $15,750

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-14 Exercise or conversion : show line 4 in the form Restricted stock units −360 360 D
Loading xslF345X03/wf-form4_164504880629063.xml…